Stacey Fedewa, MPH, PhD

Scientific Director, Risk Factors & Screening Surveillance Research

At ACS 2014-2021 (and 2008-2012)

Stacey Fedewa, PhD, MPH, is the scientific director in the Risk Factors & Screening Surveillance team within Surveillance & Health Equity Science at the American Cancer Society (ACS). She is responsible for cancer screening and early detection research and examines disparities and access to cancer screening and the quality of it. She also examines how health policies and public health recommendations influence screening utilization and early detection.

Research focus and accomplishments

Fedewa’s work has been used to inform national roundtables on colorectal cancer screening, HPV vaccination, and lung cancer. She’s been invited to speak at scientific conferences, most recently at the American Association for Cancer Research’s COVID-19 and Cancer conference.  


Fedewa co-authors Cancer Prevention and Early Detection Facts and Figures and contributes to other Facts and Figures publications.

Fedewa has published over 100 peer-reviewed articles, 2 book chapters, and in 2015, received a “Most Cited” award from the scientific journal Cancer Epidemiology Biomarkers and Prevention.

For a full list of Fedewa’s publications, visit her Google Scholar page.

Work before ACS

  • Emory University, Department of Epidemiology, Graduate Research Assistant
  • American Cancer Society, Surveillance and Health Services Research, Program Manager
  • Gharbiah Cancer Society in Tanta, Egypt, Research Assistant
  • University of Michigan, School of Public Health, Research Associate


  • PhD: Epidemiology, Rollins School of Public Health, Emory University, 2016
  • MPH: Epidemiology, University of Michigan, 2008
  • BS: Movement Science, University of Michigan, 2004

Personal life 

I live in Atlanta with my daughter. In my free time, I enjoy spending time outdoors with family.